Sex: Male
Histology: Small cell lung cancer
Key Mutations: TP53 H179R, RB1 S567*, NOTCH1 P2Rfs*31,
MYCL Amplified
Molecular Characteristics: MSK-IMPACT, whole exome sequencing
Matched Normal: Yes
Treatment: LDE225 + cisplatin + etoposide, extensive cisplatin and
etoposide treatment in PDX
Site: Lung
Paired: Yes
Comments: Chemoresistant
Licensing Information: Corporations and other for-profit entities may nonexclusively license Memorial Sloan Kettering’s tangible materials for research or commercial purposes. For more information, please contact [email protected].
Stage of Development
Ready to use